Références
European Medicines Agency (2017) PRAC concludes assessment of gadolinium agents used in body scans and recommends regulatory actions, including suspension for some marketing authorizations. http://www.ema.europa.eu/docs/en_GB/document_library/ Press_release/2017/03/WC500223209.pdf (Dernier accès 4 septembre 2017)
Ishiguchi T, Takahashi S (2010) Safety of gadoterate meglumine (Gd-DOTA) as a contrast agent for magnetic resonance imaging: results of a post-marketing surveillance study in Japan. Drugs R D 10:133–45
Herborn CU, Honold E, Wolf M, et al (2007) Clinical safety and diagnostic value of the gadolinium chelate gadoterate meglumine (Gd-DOTA). Invest Radiol 42:58–62
Demirhan A, Yasar Tekelioglu U, Akkaya A, et al (2012) Magnetic resonance imaging contrast agent related pulmonary edema: a case report. Eur Rev Med Pharmacol Sci 16(Suppl 4):110–2
Gupta N, Davidson J, Li A (2013) Acute respiratory distress syndrome due to gadolinium administration. J Intensive Care Soc 14:159–62
Park J, Byun IH, Park KH, et al (2015) Acute respiratory distress syndrome after the use of gadolinium contrast media. Yonsei Med J 56:1155–7
Guru PK, Bohman JK, Fleming CJ, et al (2016) Severe acute cardiopulmonary failure related to gadobutrol magnetic resonance imaging contrast reaction. Mayo Clinic Proceedings 91:362–6
Combes A, Leprince P, Luyt CE, et al (2009) Assistance cardiorespiratoire par extracorporeal membrane oxygenation (ECMO). Réanimation 18:420–7
Riou B, Adnet F, Baud F, et al (2009) Recommandations sur les indications de l’assistance circulatoire dans le traitement des arrêts cardiaques réfractaires. Ann Fr Anesth Reanim 28:182–6
Parekh M, Abrams D, Brodie D (2017) Extracorporeal techniques in acute respiratory distress syndrome. Ann Transl Med 5:296
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Tran, D., Cren, P. & Capdeville, A. Œdème pulmonaire non cardiogénique fatal après injection de gadolinium. Ann. Fr. Med. Urgence 7, 396–398 (2017). https://doi.org/10.1007/s13341-017-0798-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13341-017-0798-1